0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query globaldata pharmapoint rheumatoid arthritis global drug forecast market analysis 2025.Your search for "" gave back 1533058 results.
Melanocyte Stimulating Hormone Receptor - Pipeline Review, H2 2019 Summary According to the recently published report 'Melanocyte Stimulating...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
The global Systemic Autoimmune Disease Diagnostics market size was valued at US$ million in 2023. With growing demand in downstream market, the...
Catalog:
LPI
February 2024
Price: USD 3,660.00
The global Arthritic Therapeutic market size was valued at US$ 26650 million in 2023. With growing demand in downstream market, the Arthritic...
Catalog:
LPI
March 2024
Price: USD 3,660.00
Integrin Beta 1 - Pipeline Review, H2 2019 Summary Integrin Beta 1 (Fibronectin Receptor Subunit Beta or Glycoprotein Iia or VLA 4 Subunit Beta or...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
Polyarticular Juvenile Idiopathic Arthritis (PJIA) - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and...
Catalog:
Global Markets Direct
May 2018
Price: USD 2,000.00
Enbrel is a biopharmaceutical that treats autoimmune diseases by interfering with tumor necrosis factor (TNF, a soluble inflammatory cytokine) by...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Abatacept (marketed as Orencia) is a drug used to treat autoimmune diseases like rheumatoid arthritis, by interfering with the immune activity of T...
Catalog:
GIR
January 2023
Price: USD 3,480.00
Interleukin 1 - Pipeline Review, H2 2020 Summary Interleukin 1 (IL1) pipeline Target constitutes close to 30 molecules. Out of which approximately 29...
Catalog:
Global Markets Direct
July 2020
Price: USD 3,500.00
Tofacitinib, also known as Xeljanz, is a type of drug known as a Janus kinase (JAK) inhibitor. It works by blocking the action of Janus kinase...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Melanocortin Receptor 4 (MC4R) - Pipeline Review, H2 2018 Summary Melanocortin Receptor 4 (MC4R) - Melanocortin 4 receptor (MC4R) is a G protein-...
Catalog:
Global Markets Direct
September 2018
Price: USD 3,500.00
The global Infliximab and Biosimilar market size was valued at US$ million in 2023. With growing demand in downstream market, the Infliximab and...
Catalog:
LPI
February 2024
Price: USD 3,660.00
Melanocortin Receptor 4 - Pipeline Review, H2 2019 Summary Melanocortin Receptor 4 (MC4R) pipeline Target constitutes close to 9 molecules. Out of...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
Tyrosine Protein Kinase JAK2 - Pipeline Review, H1 2020 Summary Tyrosine Protein Kinase JAK2 (Janus Kinase 2 or JAK2 or EC 2.7.10.2) - Janus kinase 2...
Catalog:
Global Markets Direct
January 2020
Price: USD 3,500.00
Toll Like Receptor 8 (CD288 or TLR8) - Pipeline Review, H2 2019 Summary Toll Like Receptor 8 (CD288 or TLR8) pipeline Target constitutes close to 22...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Pipeline Review, H1 2019 Summary Interleukin...
Catalog:
Global Markets Direct
April 2019
Price: USD 3,500.00
